Home 2022

Human cytomegalovirus

Gene Therapy Turns to the Use of Synthetic Biology Principles
Bioprocessing

Gene Therapy Turns to the Use of Synthetic Biology Principles

John Sterling -
0
Immune Surrogate Finding May Accelerate CMV Vaccine Development
Drug Discovery

Immune Surrogate Finding May Accelerate CMV Vaccine Development

John Sterling -
0
Cytomegalovirus’ Immune Evasion Tactics Uncovered
Featured

Cytomegalovirus’ Immune Evasion Tactics Uncovered

Jeffrey S. Buguliskis, Ph.D. -
0
mRNA-Based Drugs Prepare to Go the Distance
Drug Discovery

mRNA-Based Drugs Prepare to Go the Distance

Kathy Liszewski -
0
Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines
Drug Discovery

Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines

GEN Staff Writer -
0
Brain Cancer Vaccine–Chemotherapy Combo Shows Promise
Cancer

Brain Cancer Vaccine–Chemotherapy Combo Shows Promise

GEN Staff Writer -
0
Positive Phase III Data for Merck Candidates against CMV and Shingles
Drug Discovery

Positive Phase III Data for Merck Candidates against CMV and Shingles

GEN Staff Writer -
0
Chimerix Axes 20% of Workforce, Citing Phase III Failure
Drug Discovery

Chimerix Axes 20% of Workforce, Citing Phase III Failure

GEN Staff Writer -
0
Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial
Drug Discovery

Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial

GEN Staff Writer -
0
Chimerix Names New CEO, a Month after Compassionate Use Flap
News

Chimerix Names New CEO, a Month after Compassionate Use Flap

GEN Staff Writer -
0
1234Page 1 of 4
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.